Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and Substance Withdrawal Syndrome

methoxyhydroxyphenylglycol has been researched along with Substance Withdrawal Syndrome in 65 studies

Research

Studies (65)

Timeframe	Studies, this research(%)	All Research%
pre-1990	39 (60.00)	18.7374
1990's	14 (21.54)	18.2507
2000's	6 (9.23)	29.6817
2010's	6 (9.23)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Scheyer, AF; Tseng, KY; Wolf, ME	1
Fujimiya, T; Liu, J	1
Everhart, T; Harris, DS; Jacob, P; Jones, RT; Lin, E; Mendelson, JE	1
Kitanaka, J; Kitanaka, N; Morita, Y; Nishiyama, N; Takemura, M; Tanaka, K; Tatsuta, T; Watabe, K	1
Laorden, ML; Milanés, MV; Navarro-Zaragoza, J; Núñez, C	1
Laorden, ML; Milanés, MV; Navarro-Zaragoza, J; Núñez, C; Ruiz-Medina, J; Valverde, O	1
Ben-Shahar, O; Caruana, AL; Ditzhazy, J; Gordon, EJ; Kippin, TE; Miller, BW; Ploense, KL; Sacramento, AD; Silva, HE; Szumlinski, KK; Webb, SM; Wroten, MG	1
Bissette, G; Heinz, A; Hommer, D; Jones, DW; Knable, M; Linnoila, M; Ragan, P; Weinberger, DR; Wellek, S	1
Berman, J; Gonzalez, B; Roy, A; Roy, M	1
Cerezo, M; Laorden, ML; Milanés, MV	1
Lader, M; Petursson, H	1
Charney, DS; Redmond, DE	1
Ahluwalia, P; Singhal, RL	1
Fujimoto, A	1
Bond, PA; Lader, MH; Petursson, H; Smith, B	1
Charney, DS; Elsworth, JD; Jablons, DM; Maas, JW; Redmond, DE; Roth, RH; Swann, AC	1
Ebert, MH; Gordon, EK; Kopin, IJ; Martin, PR; Weingartner, H	1
Hawley, RJ; Linnoila, M; Major, LF	1
Charney, DS; Galloway, MP; Heninger, GR; Kleber, HD; Murberg, M; Redmond, DE; Roth, RH	1
Emrick, C; Freedman, R; Lubman, A; Mosimann, WF	1
Charney, DS; Heninger, GR; Landis, H; Sternberg, DE	1
Elsworth, JD; Redmond, DE; Roth, RH	1
Davis, JM; De Leon-Jones, FA; Dekirmenjian, H; Inwang, EE	1
Barchas, JD; Madden, J; Mefford, IN	1
Borg, S; Kvande, H; Sedvall, G	1
Hollister, LE	1
Hollister, LE; Kanaske, K; Knopes, K; Prusmack, JJ	1
Gibson, CJ	1
Agren, H; Gurklis, J; O'Connor, DT; Peters, JL; van Kammen, DP; Yao, JK	1
Gilbertson, MW; Gurklis, JA; Kelley, ME; Peters, JL; van Kammen, DP; Yao, JK	1
Black, JE; Heninger, GR; Kosten, TR; Malison, RT; McDougle, CJ; Price, LH; Zimmermann, RC	1
Funada, M; Misawa, M; Mizoguchi, H; Narita, M; Suzuki, T; Tsuda, M	1
Ahtee, L; Airio, J; Attila, M	1
Nakamura, J; Uchimura, N	1
Kamei, J; Ohsawa, M	1
Bowers, MB; Kosten, TR; Malison, RT; Seibyl, JP	1
Cooney, N; D'Souza, C; Gil, R; Heninger, G; Krasnicki, S; Krystal, JH; Petrakis, IL; Trevisan, L; Webb, E	1
George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM	1
Laorden, ML; Milanés, MV	1
Charney, DS; Kosten, TR; Krystal, JH; Petrakis, IL; Southwick, SM; Stine, SM	1
Lapierre, YD; Rastogi, RB; Singhal, RL	1
Helmeste, DM; Stancer, HC; Tang, SW	1
Brown, GM; Gupta, RN; Harman, J; Moldofsky, H; Murphy, JT; Stancer, HC	1
Babor, T; Grab, E; McDougle, M; Meyer, RE; Mirin, SM; Orsulak, PJ; Platz, PA; Randall, M; Schildkraut, JJ	1
Crawley, JN; Laverty, R; Roth, RH	1
Cassens, G; Kuruc, A; Orsulak, PJ; Schildkraut, JJ	1
Cameron, OG; Garcia, AW; Pomerleau, CS; Pomerleau, OF	1
Heninger, GR; Kleber, HD; Kosten, TR; McDougle, CJ; Palumbo, JM; Price, LH	1
Kleber, HD; Kosten, TR; Morgan, C	1
Gurklis, J; Nofzinger, E; O'Connor, D; Peters, JL; van Kammen, DP; Yao, J	1
Beigel, Y; Cygielman, G; Modai, I	1
Ahtee, L; Attila, LM; Carlson, KR; Haikala, H	1
Goetz, KL; Linnoila, M; Nugent, A; Peters, J; van Kammen, DP; van Kammen, WB; Yao, J	1
Bowers, MB; Charney, DS; Glazer, WM; Heninger, GR	1
Galloway, MP; Lodhi, R; Martin, SD; Yeragani, VK	1
Charney, DS; Goodman, WK; Heninger, GR; Price, LH; Woods, SW	1
Jaskiw, G; Kirch, DG; Linnoila, M; Weinberger, DR; Wyatt, RJ	1
Bongianni, F; Carla, V; Moroni, F; Pellegrini-Giampietro, DE	1
Molyneux, S; Nutt, D	1
Elsworth, JD; Garcia, EJ; Grant, SJ; Redmond, DE; Roth, RH; Taylor, JR	1
Jarrott, B; Lewis, SJ; Rowe, P	1
Borg, S; Liljeberg, P; Mossberg, D	1
Anderson, GM; Caruso, KA; Cohen, DJ; Leckman, JF; Ort, S; Riddle, MA	1
Fenerty, JP; Finkelstein, MF; Galloway, MP; Grant, SJ; Mayor, R; Redmond, DE; Roth, RH	1
Hawley, RJ; Linnoila, M; Major, LF; Schulman, EA	1

Reviews

2 review(s) available for methoxyhydroxyphenylglycol and Substance Withdrawal Syndrome

Article	Year
Neurobiological mechanisms in human anxiety. Evidence supporting central noradrenergic hyperactivity. Neuropharmacology, 1983, Volume: 22, Issue:12B Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Humans; Locus Coeruleus; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Substance Withdrawal Syndrome	1983
[Changes in metabolism of catecholamines and serotonin during alcohol withdrawal]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl Topics: Antidepressive Agents, Second-Generation; Dopamine; Ethanol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Mianserin; Norepinephrine; Serotonin; Substance Withdrawal Syndrome	1997

Trials

9 trial(s) available for methoxyhydroxyphenylglycol and Substance Withdrawal Syndrome

Article	Year
A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. BMC clinical pharmacology, 2009, Aug-01, Volume: 9 Topics: Administration, Cutaneous; Adult; Affect; Amphetamine; Amphetamines; Analysis of Variance; Cocaine; Dopamine Uptake Inhibitors; Drug Interactions; Female; Homovanillic Acid; Humans; Infusions, Intravenous; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Monitoring, Physiologic; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Prolactin; Selegiline; Statistics, Nonparametric; Substance Withdrawal Syndrome; Young Adult	2009
Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity. Life sciences, 1984, Sep-17, Volume: 35, Issue:12 Topics: Adult; Blood Pressure; Brain; Female; Humans; Kinetics; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Narcotics; Norepinephrine; Substance Withdrawal Syndrome; Substance-Related Disorders	1984
Abrupt discontinuation of tricyclic antidepressant drugs: evidence for noradrenergic hyperactivity. The British journal of psychiatry : the journal of mental science, 1982, Volume: 141 Topics: Adult; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Substance Withdrawal Syndrome	1982
Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Archives of general psychiatry, 1994, Volume: 51, Issue:9 Topics: Administration, Intranasal; Adult; Cocaine; Double-Blind Method; Female; Hospitalization; Humans; Hydrocortisone; Infusions, Intravenous; Insufflation; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Prospective Studies; Single-Blind Method; Substance Withdrawal Syndrome; Substance-Related Disorders; Yohimbine	1994
Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal. Biological psychiatry, 1998, Feb-15, Volume: 43, Issue:4 Topics: Adult; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methoxyhydroxyphenylglycol; Middle Aged; Narcotics; Nerve Tissue Proteins; Substance Withdrawal Syndrome; Tomography, Emission-Computed, Single-Photon	1998
Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biological psychiatry, 2002, Apr-15, Volume: 51, Issue:8 Topics: Adrenergic alpha-Antagonists; Adult; Analgesics, Opioid; Anxiety; Blood Pressure; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Methadone; Methoxyhydroxyphenylglycol; Opioid-Related Disorders; Substance Withdrawal Syndrome; Yohimbine	2002
Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone. NIDA research monograph, 1992, Volume: 121 Topics: Adult; Blood Pressure; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome	1992
Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases. The American journal of psychiatry, 1986, Volume: 143, Issue:7 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Pressure; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Pilot Projects; Substance Withdrawal Syndrome	1986
Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients. Psychiatry research, 1988, Volume: 25, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Brain; Catecholamines; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome	1988

Other Studies

54 other study(ies) available for methoxyhydroxyphenylglycol and Substance Withdrawal Syndrome

Article	Year
A protein synthesis-dependent mechanism sustains calcium-permeable AMPA receptor transmission in nucleus accumbens synapses during withdrawal from cocaine self-administration. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Feb-19, Volume: 34, Issue:8 Topics: Animals; Benzoates; Calcium; Cocaine-Related Disorders; Cycloheximide; Excitatory Amino Acid Antagonists; Glycine; Male; Methoxyhydroxyphenylglycol; Nucleus Accumbens; Patch-Clamp Techniques; Protein Biosynthesis; Protein Synthesis Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Self Administration; Substance Withdrawal Syndrome; Synapses; Synaptic Transmission; Thiazoles; Ventral Tegmental Area	2014
Abrupt termination of an ethanol regimen provokes ventricular arrhythmia and enhances susceptibility to the arrhythmogenic effects of epinephrine in rats. Alcoholism, clinical and experimental research, 2010, Volume: 34 Suppl 1 Topics: Alcoholism; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Electrocardiography; Epinephrine; Ethanol; Heart Rate; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Sympathetic Nervous System; Vagus Nerve	2010
Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice. Neurochemical research, 2010, Volume: 35, Issue:5 Topics: Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Substance Withdrawal Syndrome	2010
Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal. Molecular pharmacology, 2010, Volume: 77, Issue:5 Topics: Adrenocorticotropic Hormone; Animals; Brain; Brain Stem; Corticosterone; Iodine Radioisotopes; Male; Methoxyhydroxyphenylglycol; Morphine; Norepinephrine; Proto-Oncogene Proteins c-fos; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stress, Psychological; Substance Withdrawal Syndrome; Substance-Related Disorders; Tyrosine 3-Monooxygenase	2010
CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats. British journal of pharmacology, 2011, Volume: 162, Issue:4 Topics: Animals; Enzyme Activation; Hypothalamo-Hypophyseal System; Male; Methoxyhydroxyphenylglycol; Molecular Targeted Therapy; Morphine Dependence; Nerve Tissue Proteins; Neurons; Norepinephrine; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Phosphorylation; Pituitary-Adrenal System; Protein Processing, Post-Translational; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Signal Transduction; Solitary Nucleus; Substance Withdrawal Syndrome; Tyrosine 3-Monooxygenase	2011
Deficits in ventromedial prefrontal cortex group 1 metabotropic glutamate receptor function mediate resistance to extinction during protracted withdrawal from an extensive history of cocaine self-administration. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Jan-09, Volume: 33, Issue:2 Topics: Animals; Blotting, Western; Cocaine-Related Disorders; Conditioning, Operant; Cues; Excitatory Amino Acid Antagonists; Extinction, Psychological; Injections; Male; Methoxyhydroxyphenylglycol; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Recurrence; Self Administration; Substance Withdrawal Syndrome	2013
Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism]. Pharmacopsychiatry, 2002, Volume: 35, Issue:4 Topics: Adult; Affect; Alcoholism; Carrier Proteins; Case-Control Studies; Corticotropin-Releasing Hormone; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methoxyhydroxyphenylglycol; Middle Aged; Nerve Tissue Proteins; Raphe Nuclei; Serotonin Plasma Membrane Transport Proteins; Substance Withdrawal Syndrome; Tomography, Emission-Computed, Single-Photon	2002
Cerebrospinal fluid monoamine metabolites in cocaine patients: no relationship to cue-induced craving. Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:3 Topics: Adult; Cocaine; Cocaine-Related Disorders; Cues; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Motivation; Norepinephrine; Serotonin; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome	2002
Inhibition of protein kinase C but not protein kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis. European journal of pharmacology, 2002, Sep-27, Volume: 452, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Blood-Brain Barrier; Catecholamines; Chromatography, High Pressure Liquid; Corticosterone; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Hypothalamo-Hypophyseal System; Isoquinolines; Male; Methoxyhydroxyphenylglycol; Morphine; Naphthalenes; Norepinephrine; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Protein Kinase C; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Sulfonamides	2002
Long-term effects of benzodiazepines. Neuropharmacology, 1983, Volume: 22, Issue:4 Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Brain; Drug Tolerance; Electroencephalography; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Radiography; Substance Withdrawal Syndrome	1983
Comparison of the changes in central catecholamine systems following short- and long-term lithium treatment and the consequences of lithium withdrawal. Neuropsychobiology, 1984, Volume: 12, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catecholamines; Dopamine; Homovanillic Acid; Humans; Lithium; Lithium Carbonate; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Substance Withdrawal Syndrome; Time Factors; Tyrosine 3-Monooxygenase	1984
[Cerebrospinal fluid monamine metabolites and cyclic nucleotides during alcoholic withdrawal syndrome]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 1980, Volume: 82, Issue:5 Topics: Adult; Alcoholism; Brain; Cyclic AMP; Cyclic GMP; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Substance Withdrawal Syndrome	1980
Monoamine metabolism during chronic benzodiazepine treatment and withdrawal. Biological psychiatry, 1983, Volume: 18, Issue:2 Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Long-Term Care; Male; Methoxyhydroxyphenylglycol; Phenylacetates; Substance Withdrawal Syndrome; Vanilmandelic Acid	1983
Brain catecholamine metabolites and behavior in morphine withdrawal. European journal of pharmacology, 1982, Dec-24, Volume: 86, Issue:2 Topics: Animals; Behavior, Animal; Brain Chemistry; Catecholamines; Debrisoquin; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Morphine Dependence; Rats; Receptors, Opioid; Substance Withdrawal Syndrome; Synaptosomes	1982
Catecholamine metabolism during clonidine withdrawal. Psychopharmacology, 1984, Volume: 84, Issue:1 Topics: Aged; Catecholamines; Clonidine; Epinephrine; Female; Heart Rate; Humans; Male; Memory; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Substance Withdrawal Syndrome; Time Factors; Vanilmandelic Acid	1984
The role of the central noradrenergic nervous system in the mediation of the ethanol intoxication and ethanol withdrawal syndrome. Psychopharmacology bulletin, 1984,Summer, Volume: 20, Issue:3 Topics: Adult; Aged; Alcoholic Intoxication; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Substance Withdrawal Syndrome; Sympathetic Nervous System	1984
Altered mood and norepinephrine metabolism following withdrawal from alcohol. Drug and alcohol dependence, 1983, Volume: 12, Issue:1 Topics: Alcoholism; Creatinine; Depression; Emotions; Female; Humans; Male; Methoxyhydroxyphenylglycol; MMPI; Norepinephrine; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome	1983
Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates. The Journal of clinical psychiatry, 1982, Volume: 43, Issue:6 Pt 2 Topics: Animals; Brain; Clonidine; Dose-Response Relationship, Drug; Haplorhini; Humans; Methoxyhydroxyphenylglycol; Morphine Dependence; Naloxone; Neurons; Norepinephrine; Rats; Substance Withdrawal Syndrome	1982
Excretion of catecholamine metabolites during methadone maintenance and withdrawal. Archives of general psychiatry, 1983, Volume: 40, Issue:8 Topics: Adult; Epinephrine; Female; Heroin Dependence; Humans; Male; Metanephrine; Methadone; Methoxyhydroxyphenylglycol; Norepinephrine; Normetanephrine; Substance Withdrawal Syndrome; Substance-Related Disorders; Vanilmandelic Acid	1983
Clonidine: basic and clinical perspectives. The Journal of clinical psychiatry, 1982, Volume: 43, Issue:6 Pt 2 Topics: Animals; Clonidine; Humans; Locus Coeruleus; Methoxyhydroxyphenylglycol; Norepinephrine; Opioid-Related Disorders; Substance Withdrawal Syndrome	1982
Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science (New York, N.Y.), 1981, Sep-04, Volume: 213, Issue:4512 Topics: Adrenergic Fibers; Alcoholism; Brain; Ethanol; Glycols; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Substance Withdrawal Syndrome	1981
Excretion of 3-methoxy-4-hydroxyphenylglycol in depressed and geriatric patients and normal persons. International pharmacopsychiatry, 1981, Volume: 16, Issue:3 Topics: Adult; Aged; Aging; Alcoholism; Depressive Disorder; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Reference Values; Substance Withdrawal Syndrome	1981
Asthma and alcohol withdrawal as sources of artefact in urinary excretion of 3-methoxy-4-hydroxyl phenylglycol (MHPG). Communications in psychopharmacology, 1980, Volume: 4, Issue:2 Topics: Adult; Alcoholism; Asthma; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Substance Withdrawal Syndrome	1980
Caffeine withdrawal elevates urinary MHPG excretion. The New England journal of medicine, 1981, Feb-05, Volume: 304, Issue:6 Topics: Caffeine; Humans; Methoxyhydroxyphenylglycol; Substance Withdrawal Syndrome	1981
Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. The American journal of psychiatry, 1994, Volume: 151, Issue:3 Topics: Adult; Chromogranin A; Chromogranins; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Logistic Models; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Placebos; Probability; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome	1994
Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia. Archives of general psychiatry, 1995, Volume: 52, Issue:8 Topics: Adult; Age of Onset; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Logistic Models; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Placebos; Probability; Psychiatric Status Rating Scales; Recurrence; Regression Analysis; ROC Curve; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome	1995
Diazepam pretreatment suppresses morphine withdrawal signs in the mouse. Life sciences, 1996, Volume: 58, Issue:4 Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Animals; Anti-Anxiety Agents; Anticonvulsants; Cerebral Cortex; Diazepam; Drug Combinations; gamma-Aminobutyric Acid; Male; Methoxyhydroxyphenylglycol; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Norepinephrine; Receptors, GABA-A; Substance Withdrawal Syndrome	1996
Regional differences in cerebral noradrenaline turnover in mice withdrawn from repeated morphine treatment and tolerance to the effects of acute morphine. Pharmacology & toxicology, 1995, Volume: 77, Issue:3 Topics: alpha-Methyltyrosine; Analysis of Variance; Animals; Brain Stem; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypothalamus; Injections, Subcutaneous; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Mice; Morphine; Motor Activity; Narcotics; Norepinephrine; Prosencephalon; Substance Withdrawal Syndrome	1995
Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes. Life sciences, 1997, Volume: 60, Issue:15 Topics: Analgesics, Opioid; Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Frontal Lobe; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Norepinephrine; Receptors, Adrenergic; Substance Withdrawal Syndrome	1997
CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving? Alcoholism, clinical and experimental research, 1999, Volume: 23, Issue:8 Topics: Adult; Alcoholism; Behavior, Addictive; Biogenic Monoamines; Biomarkers; Case-Control Studies; Ethanol; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Substance Withdrawal Syndrome	1999
Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry research, 1999, Dec-20, Volume: 89, Issue:2 Topics: Adult; Case-Control Studies; Dehydroepiandrosterone; Depression; Ethanol; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics, Nonparametric; Substance Withdrawal Syndrome	1999
Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus. Life sciences, 2000, Jan-21, Volume: 66, Issue:9 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Corticosterone; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Weight Loss	2000
Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1, 4-benzodiazepines. Progress in neuro-psychopharmacology, 1978, Volume: 2, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Brain; Brain Chemistry; Bromazepam; Diazepam; Dopamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Rats; Serotonin; Substance Withdrawal Syndrome	1978
The effect of clonidine withdrawal on total 3-methoxy-4-hydroxyphenylglycol in the rat brain. Psychopharmacology, 1979, Mar-14, Volume: 61, Issue:1 Topics: Animals; Brain; Clonidine; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Rats; Substance Withdrawal Syndrome; Time Factors	1979
Withdrawal from long-term high-dose desipramine therapy. Clinical and biological changes. Archives of general psychiatry, 1978, Volume: 35, Issue:10 Topics: Adult; Desipramine; Electrocardiography; Electroencephalography; Growth Hormone; Heart Block; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Prognosis; Sleep Wake Disorders; Sleep, REM; Substance Withdrawal Syndrome	1978
Opiates, catecholamines, behavior, and mood. Psychopharmacology, 1978, Apr-11, Volume: 56, Issue:3 Topics: Adult; Behavior; Catecholamines; Emotions; Heroin; Humans; Male; Methadone; Methoxyhydroxyphenylglycol; Narcotics; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome	1978
Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal. European journal of pharmacology, 1979, Aug-01, Volume: 57, Issue:2-3 Topics: Animals; Clonidine; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Morphine Dependence; Naloxone; Norepinephrine; Rats; Substance Withdrawal Syndrome	1979
Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat. Communications in psychopharmacology, 1979, Volume: 3, Issue:4 Topics: Animals; Brain Chemistry; Dextroamphetamine; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Rats; Substance Withdrawal Syndrome	1979
The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report. Psychoneuroendocrinology, 1992, Volume: 17, Issue:6 Topics: Adult; Estradiol; Female; Humans; Hydrocortisone; Menstrual Cycle; Methoxyhydroxyphenylglycol; Nicotine; Norepinephrine; Progesterone; Smoking; Smoking Cessation; Substance Withdrawal Syndrome	1992
Dopaminergic responsivity during cocaine abstinence: a pilot study. Psychiatry research, 1992, Volume: 43, Issue:1 Topics: Adult; Carbidopa; Cocaine; Dopamine Agents; Drug Combinations; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prolactin; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders	1992
CSF noradrenergic activity and sleep EEG in clinically stable schizophrenic patients after haloperidol withdrawal. Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A Topics: Adult; Dopamine beta-Hydroxylase; Electroencephalography; Haloperidol; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Schizophrenia; Sleep; Sleep, REM; Substance Withdrawal Syndrome	1992
Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment. The Journal of clinical psychiatry, 1986, Volume: 47, Issue:2 Topics: Bipolar Disorder; Delirium; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Phenelzine; Substance Withdrawal Syndrome	1986
Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state. The Journal of pharmacology and experimental therapeutics, 1989, Volume: 249, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Biogenic Amines; Brain; Dopamine; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Morphine; Rats; Rats, Inbred Strains; Self Administration; Substance Withdrawal Syndrome	1989
CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal. Biological psychiatry, 1989, Volume: 26, Issue:2 Topics: Adult; Chromatography, High Pressure Liquid; Chronic Disease; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Psychiatric Status Rating Scales; Recurrence; Risk Factors; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome	1989
The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia. Biological psychiatry, 1989, Volume: 26, Issue:3 Topics: Antipsychotic Agents; Brain; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome	1989
Clinical ratings and plasma HVA during cocaine abstinence. Biological psychiatry, 1989, Volume: 26, Issue:4 Topics: Adult; Cocaine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders	1989
Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. British journal of pharmacology, 1986, Volume: 88, Issue:3 Topics: Animals; Behavior, Animal; Brain Chemistry; Calcium Channel Blockers; Methoxyhydroxyphenylglycol; Morphine; Morphine Dependence; Naloxone; Nicotinic Acids; Nimodipine; Norepinephrine; Rats; Receptors, Opioid; Substance Withdrawal Syndrome; Verapamil	1986
Benzodiazepines, plasma MHPG and alpha-2-adrenoceptor function in man. International clinical psychopharmacology, 1987, Volume: 2, Issue:2 Topics: Brain; Clonidine; Diazepam; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Psychomotor Performance; Receptors, Adrenergic; Substance Withdrawal Syndrome	1987
Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology, 1988, Volume: 96, Issue:1 Topics: Animals; Behavior, Animal; Body Weight; Brain Chemistry; Clonidine; Hippocampus; Injections; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome	1988
Involvement of hypothalamic adrenaline in the clonidine withdrawal syndrome in normotensive and spontaneously hypertensive rats. Clinical and experimental pharmacology & physiology, 1988, Volume: 15, Issue:10 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clonidine; Dopamine; Epinephrine; Female; Hypothalamus; Medulla Oblongata; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Substance Withdrawal Syndrome; Time Factors	1988
Clinical studies on central noradrenergic activity in alcohol abusing patients. Acta psychiatrica Scandinavica. Supplementum, 1986, Volume: 327 Topics: Adrenergic Fibers; Alcoholism; Central Nervous System; Ethanol; Glycols; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Substance Withdrawal Syndrome	1986
Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects. Archives of general psychiatry, 1986, Volume: 43, Issue:12 Topics: Adolescent; Blood Pressure; Child; Clonidine; Epinephrine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Pulse; Serotonin; Substance Withdrawal Syndrome; Tourette Syndrome	1986
Precipitated diazepam withdrawal elevates noradrenergic metabolism in primate brain. European journal of pharmacology, 1985, Jan-02, Volume: 107, Issue:2 Topics: Animals; Behavior, Animal; Benzodiazepinones; Brain; Chlorocebus aethiops; Diazepam; Female; Flumazenil; Humans; Male; Methoxyhydroxyphenylglycol; Narcotics; Norepinephrine; Substance Withdrawal Syndrome	1985
Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlations with clinical signs. Archives of general psychiatry, 1985, Volume: 42, Issue:11 Topics: Adult; Anorexia; Blood Pressure; Diastole; Ethanol; Glycols; Hallucinations; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychomotor Agitation; Pulse; Sleep Wake Disorders; Substance Withdrawal Syndrome; Sweating; Systole; Tremor	1985